Description
Book SynopsisThis book follows on from the previous two books in the series, which have been of great value to Doctors, Pharmacists, and Patients. Written by experienced LDN Specialists with a wealth of experience, they share case studies and endless references to clinical trials and published papers. Included in the book: Pharmacology and Best Clinical Practices, Dosing Protocols, Drug-Resistant Depression, Virally Damaged Tissues (COVID-19, Herpes Simplex (HSV 1 & 2), Varicella-Zoster, Human Parvovirus B19 (B19V), Epstein-Barr (EBV), Longevity, Mixed Connective Tissue Disease, Mold Illness and CIRS, Ophthalmic Conditions, Long COVID and Cancer.
Trade Review"This book is gold! It is a science-based, effective solution to the rampant chronic health problems that plague millions today. It is easy to understand, simple to implement, and most importantly, will be a guiding light for so many who are out of answers and are desperately searching for a path home to health." by Dr. Mindy Pelz, DC - Bestselling author of The Reset Factor, The Reset Factor Kitchen, and The Menopause Reset "Building on the valuable information shared in the first two volumes of The LDN Book, book three is an equally important and authoritative treasure trove of documented research furthering our understanding of naltrexone. Essential reading for clinicians and patients alike!" by Larry Trivieri, Jr. - Author and Health Freedom Advocate "Praises to Linda Elsegood through the LDN Research Trust for once again compiling such a comprehensive, informative book on LDN and its multitude of uses, filled with so many practical and relevant usages of LDN! I would highly recommend it to all who are interested in the potential of LDN's efficacy in today's integrative world. This book contains current clinical research, up-to-date protocols, and appropriate dosing for LDN. I cannot speak more highly of such a pertinent book regarding LDN!" by Lisa Hunt, DO, DOH - Specializing in strengthening the immune system, anti-aging, etc "The LDN Book 3 Is an invaluable resource for all clinicians that treat patients suffering from chronic inflammatory conditions. The book offers detailed references, protocols, insight, and information on how to use low dose naltrexone to treat CIRS, latent viral infections, autoimmune conditions, refractive depression, and many other challenging conditions. Like the previous two books, Book 3 is a must-have for any physician." by Alina D Garcia MD - Specializing in fibromyalgia, chronic fatigue, Lyme and CIRS, etc "Rarely does a naturopathic doctor consider any medicine to be a "miracle drug," but LDN has been a life-altering medicine for my patients. Kudos to Linda Elsegood for once again offering a resource for patients worldwide." by Dr. Nancy L. Evans, ND - Specializing in HRT and thyroid disorders "A wonderful resource to build upon patients' and clinicians' knowledge of LDN by addressing current research and new applications of the medication." by Dr. Jennifer Rickner, PharmD, RP - Compounding Pharmacist and LDN Specialist "The LDN Books continue to be a treasure chest of information. We recommend them to our patients and practitioners. Book 3 carries on this tradition of being a timely and valuable resource on the many conditions that benefit from LDN." by Steve Hoffart, PharmD - Compounding Pharmacist "The LDN Book 3 gives valuable insight into the drug of the decade. The immense knowledge within can change and improve the quality of life. For many, it's a game changer." by Nat Jones, R.Ph. FAPC - Clinical Compounding Pharmacist
Table of ContentsPreface - Linda Elsegood Foreword - Pamela W. Smith, MD, MPH, MS CHAPTER ONE - Pharmacology and Best Clinical Practices - J. Stephen Dickson, BSC (HONS), MRPharmS CHAPTER TWO - Drug-Resistant Depression - Elizabeth Livengood, NMD CHAPTER THREE - Virally Damaged Tissues - Sarah J. Zielsdorf, MD, MS CHAPTER FOUR - LDN and Longevity - Yusuf M. (JP) Saleeby, MD CHAPTER FIVE - Mixed Connective Tissue Disease - Deanna Windham, DO CHAPTER SIX - Mold Illness and CIRS - Kent Holtorf, MD CHAPTER SEVEN - Ophthalmic Conditions - Sebastian Denison, BSc. (Pharm), RPh CHAPTER EIGHT - Long COVID - Professor Angus G. Dalgleish, FRCP FRCPath FMedSci and Wai M. Liu, PhD CHAPTER NINE - Cancer Case Studies - Professor Angus G. Dalgleish, FRCP FRCPath FMedSci and Wai M. Liu, PhD and Nasha Winters, ND, FABNO Epilogue - Yoon Hang "John" Kim, MD APPENDIX - Dosing Protocols - Sarah J. Zielsdorf, MD, MS Acknowledgements Contributors Notes Index
